Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


WorldHeart starts VAD trial

This article was originally published in The Gray Sheet

Executive Summary

Human implantation of the firm's rotary ventricular assist device (VAD) occurred March 8 in Greece, kicking off a feasibility trial for the device. WorldHeart will seek a bridge-to-transplant indication initially, but eventually aspires to sell the device as a destination therapy. The firm received approval from the Greek Ministry of Health to begin the trial in February (1"The Gray Sheet" Feb. 20, 2006, In Brief)...

Related Content

Financings In Brief
WorldHeart to begin rotary VAD trial



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts